Heteroaryl compounds as P2Y1 receptor inhibitors
US7645778B2 · kind B2 · utility
9Cited by
24References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2006 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Nov 14, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.